| [177Lu]Lu-PSMA-617 | Lu-177 | Approved | 35 |
| [177Lu]Lu-PSMA-I&T | Lu-177 | Clinical research | 20 |
| [225Ac]Ac-PSMA-617 | Ac-225 | Clinical research | 5 |
| [225Ac]Ac-PSMA-I&T | Ac-225 | Clinical research | 4 |
| [225Ac]Ac-DOTA-YS5 | Ac-225 | Preclinical | 4 |
| [153Sm]Sm-EDTMP | Sm-153 | Approved | 3 |
| [223Ra]Ra-RaCl2 | Ra-223 | Approved | 3 |
| [177Lu]Lu-AMTG | Lu-177 | Clinical research | 3 |
| [177Lu]Lu-PSMA-ALB-56 | Lu-177 | — | 3 |
| [177Lu]Lu-AMBA | Lu-177 | — | 3 |
| [225Ac]Ac-Macropa-PEG4-YS5 | Ac-225 | — | 3 |
| [177Lu]Lu-CTT2001 | Lu-177 | Clinical research | 2 |
| [177Lu]Lu-P17-087 | Lu-177 | Clinical research | 2 |
| [177Lu]Lu-P17-088 | Lu-177 | Clinical research | 2 |
| [212Pb]Pb-PSMA-617 | Pb-212 | — | 2 |
| [177Lu]Lu-rhPSMA-7 | Lu-177 | — | 2 |
| [211At]At-PSMA-5 | At-211 | Preclinical | 2 |
| [177Lu]Lu-Ibu-DAB-PSMA | Lu-177 | Preclinical | 2 |
| [212Pb]Pb-AB001 | Pb-212 | — | 2 |
| [177Lu]Lu-PSMA-10 | Lu-177 | Preclinical | 1 |
| [47Sc]Sc-PSMA-617 | Sc-47 | Preclinical | 1 |
| [161Tb]Tb-RM2 | Tb-161 | Preclinical | 1 |
| [161Tb]Tb-PSMA-I&T | Tb-161 | Clinical research | 1 |
| [188Re]Re-188-HEDP | Re-188 | Clinical research | 1 |
| [177Lu]Lu-LuCl3 | Lu-177 | — | 1 |
| [90Y]Y-90-NM600 | Y-90 | Preclinical | 1 |
| [225Ac]Ac-90-NM600 | Ac-225 | Preclinical | 1 |
| [177Lu]Lu-NeoBOMB1 | Lu-177 | — | 1 |
| [161Tb]Tb-AMTG | Tb-161 | Preclinical | 1 |
| [177Lu]Lu-NeoB | Lu-177 | Clinical research | 1 |
| [225Ac]Ac-mcp-TDI-Y-010 | Ac-225 | Reported once | 1 |
| [177Lu]Lu-pepa-pic2-C-Hex-KuE | Lu-177 | Reported once | 1 |
| [161Tb]Tb-pepa-pic2-C-Hex-KuE | Tb-161 | Preclinical | 1 |
| [177Lu]Lu-PSMA-1-DOTA | Lu-177 | Clinical research | 1 |
| [177Lu]Lu-LW01110 | Lu-177 | Preclinical | 1 |
| [177Lu]Lu-LW01142 | Lu-177 | Reported once | 1 |
| [212Pb]Pb-DOTAM-GRPR1 | Pb-212 | Preclinical | 1 |
| [211At]At-L3-Lu | At-211 | Reported once | 1 |
| [177Lu]Lu-PEG-(DOTA)1 | Lu-177 | Preclinical | 1 |
| [177Lu]Lu-PEG-(DOTA)1(ACUPA)3 | Lu-177 | Reported once | 1 |
| [177Lu]Lu-HTK03170 | Lu-177 | Preclinical | 1 |
| [111In]3p-C-NETA-ePSMA-16 | In-111 | Preclinical | 1 |
| [177Lu]Lu-3p-C-NETA-ePSMA-16 | Lu-177 | Preclinical | 1 |
| [213Bi]Bi-3p-C-NETA-ePSMA-16 | Bi-213 | Preclinical | 1 |
| [177Lu]Lu-HTK03149 | Lu-177 | Reported once | 1 |
| [111In]BQ7859 | In-111 | Reported once | 1 |
| [90Y]Y-hu5A10 | Y-90 | Preclinical | 1 |
| [225Ac]Ac-hu5A10 | Ac-225 | Reported once | 1 |
| [177Lu]Lu-177-AAZTA5-PSMA-617 | Lu-177 | Reported once | 1 |
| [125I]I-BO530 | I-125 | Reported once | 1 |
| [131I]PSMA-769 | I-131 | Reported once | 1 |
| [131I]PSMA-769-d-tyrosine | I-131 | Preclinical | 1 |
| [177Lu]Lu-rhPSMA-10 | Lu-177 | Clinical research | |
| [161Tb]Tb-PSMA-617 | Tb-161 | Clinical research | |
| [213Bi]Bi-PSMA-617 | Bi-213 | — | |
| [177Lu]Lu-J591 | Lu-177 | Clinical research | |
| [225Ac]Ac-J591 | Ac-225 | Clinical research | |
| [177Lu]Lu-SibuDAB | Lu-177 | — | |
| [225Ac]Ac-SibuDAB | Ac-225 | Clinical research | |
| [177Lu]Lu-PSMA-617-treated | Lu-177 | Clinical research | |
| [177Lu]Lu-LNC1011 | Lu-177 | Clinical research | |
| [211At]At-astatinated | At-211 | — | |
| [177Lu]Lu-vipivotide | Lu-177 | Approved | |
| [225Ac]Ac-225-DOTA-J591 | Ac-225 | Clinical research | |